Company news

QTREX Quantum Ltd. news in 2024

QTREX Quantum Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

December 26, 2024

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

December 15, 2024

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

December 9, 2024

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

December 3, 2024

Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism

October 8, 2024

Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference

September 23, 2024

Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System

September 12, 2024

Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product

August 21, 2024

Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest

July 29, 2024

Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System

July 10, 2024

Inspira™ Announces Business Plan Targets

June 19, 2024

Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel

June 16, 2024

Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

June 12, 2024

Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector

June 4, 2024

Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

May 29, 2024

INSPIRA™ ART100 Receives FDA 510(k) Clearance

May 27, 2024

Inspira™ Announces Start of Production of the INSPIRA™ ART100

May 1, 2024

Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100

April 24, 2024

Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures

April 15, 2024

Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections

April 9, 2024

Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb

April 2, 2024

Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager

March 31, 2024

Inspira™ Technologies Reports Full Year 2023 Financial Results

March 24, 2024

Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets

March 17, 2024

Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator

March 11, 2024

Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days

March 3, 2024

Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements

February 26, 2024

Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies

February 21, 2024

Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System

February 13, 2024

Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device

February 7, 2024

Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices

January 29, 2024

Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity

January 8, 2024

Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device

January 1, 2024

Decks in 2024